Abstract
The IgE-mediated and Th2-dependent late-phase reaction remains a mechanistically enigmatic and daunting element of human allergic inflammation. In this study, we uncover the FcεRI on dendritic cells (DCs) as a key in vivo component of this form of allergy. Because rodent, unlike human, DCs lack FcεRI, this mechanism could be revealed only by using a new transgenic mouse model with human-like FcεRI expression on DCs. In the presence of IgE and allergen, FcεRI(+) DCs instructed naive T cells to differentiate into Th2 cells in vitro and boosted allergen-specific Th2 responses and Th2-dependent eosinophilia at the site of allergen exposure in vivo. Thus, FcεRI on DCs drives the cascade of pathogenic reactions linking the initial allergen capture by IgE with subsequent Th2-dominated T cell responses and the development of late-phase allergic tissue inflammation.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Allergens / toxicity
-
Animals
-
Antigens, Plant / toxicity
-
Cells, Cultured
-
Coculture Techniques
-
Dendritic Cells / immunology*
-
Dendritic Cells / metabolism
-
Dendritic Cells / pathology*
-
Female
-
Humans
-
Inflammation Mediators / metabolism*
-
Inflammation Mediators / physiology
-
Inflammation Mediators / toxicity
-
Male
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Mice, Transgenic
-
Ovalbumin / toxicity
-
Protein Binding / genetics
-
Protein Binding / immunology
-
Receptors, IgE / deficiency
-
Receptors, IgE / metabolism*
-
Receptors, IgE / physiology
-
Th2 Cells / immunology*
-
Th2 Cells / metabolism
-
Th2 Cells / pathology*
-
Time Factors
Substances
-
Allergens
-
Antigens, Plant
-
FcepsilonRI alpha-chain, human
-
Inflammation Mediators
-
Receptors, IgE
-
Bet v 1 allergen, Betula
-
Ovalbumin